代謝バイオマーカー検査の世界市場レポート 2025年

代謝バイオマーカー検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3％で42億米ドルに成長します。予測期間の成長は、精密医療への注目の高まり、個別化栄養およびウェルネスプログラムの成長、メタボリック研究への資金提供の増加、患者意識および教育の高まり、メタボリックシンドロームおよび関連疾患の有病率の上昇に起因しています。予測期間における主な動向としては、ハイスループットスクリーニング技術の進歩、人工知能の統合、バイオマーカー分析のための機械学習の統合、モバイルヘルス（mヘルス）技術の進歩、遠隔バイオマーカー検査のための遠隔医療ソリューションの拡大などが挙げられます。

糖尿病の罹患率の増加が代謝バイオマーカー検査市場の成長を促進すると予想されます。糖尿病は、体内でのインスリンの生成や適切な使用ができないために血糖値が上昇する慢性疾患です。糖尿病患者の増加は、食生活の乱れ、特に加工食品や糖分の多い飲料の多量摂取、最小限の運動で座りっぱなしのライフスタイルなどに影響されています。さらに、高齢化や糖尿病の家族歴は、遺伝的素因を示すリスク上昇の一因となっています。代謝バイオマーカー検査は、分子レベルでの代謝機能や異常に関する詳細な洞察を提供することにより、糖尿病などの代謝性疾患の診断、モニタリング、管理を支援します。例えば、2024年5月、英国を拠点とする非営利団体British Diabetic Association（英国糖尿病協会）は、英国では現在430万人が糖尿病と診断されており、2022年には2021年に比べて14万8,951件増加すると報告しています。さらに、英国では240万人以上が2型糖尿病の発症リスクが高いです。このように、糖尿病の罹患率の増加は、代謝バイオマーカー検査市場の成長を促進すると考えられます。

代謝バイオマーカー検査市場の主要企業は、ユーザーが継続的に栄養・健康指標を追跡・管理できるよう、セルフモニタリング用バイオウェアラブルなどの技術的進歩に注力しています。これらのバイオウェアラブルは、グルコースなどの主要な代謝マーカーをリアルタイムで非侵襲的にモニタリングし、個人に合わせた健康管理をサポートし、食事や運動能力を最適化します。例えば、2022年1月、米国の医療機器会社であるアボット・ラボラトリーズは、Lingoバイオウェアラブルを発表しました。上腕に最長2週間装着できるように設計されており、ユーザーはグルコース、ケトン体、乳酸値をモニターすることができ、代謝の健康状態を継続的に把握することができます。アボット社のFreeStyle Libreの技術を活用し、医療診断ツールとしてではなく、一般的な健康状態や運動能力を高めることを目的としています。最初の発売は欧州でLingo Ketoブランドで計画され、処方箋なしで消費者が直接購入できるようになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界代謝バイオマーカー検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の代謝バイオマーカー検査市場：成長率分析
• 世界の代謝バイオマーカー検査市場の実績：規模と成長, 2019-2024
• 世界の代謝バイオマーカー検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界代謝バイオマーカー検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の代謝バイオマーカー検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分離技術
• 検出技術
• その他のタイプ
• 世界の代謝バイオマーカー検査市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 心血管疾患
• 神経疾患
• 先天性代謝異常
• その他の適応症
• 世界の代謝バイオマーカー検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物評価
• ニュートリゲノミクス
• 毒性試験
• パーソナライズ医療
• 機能ゲノミクス
• その他の用途
• 世界の代謝バイオマーカー検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 診断ツール会社
• ヘルスケア情報技術（IT）
• 臨床検査室
• 世界の代謝バイオマーカー検査市場分離技術の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クロマトグラフィー
• キャピラリー電気泳動
• 質量分析（MS）
• 液液抽出
• 固相抽出
• 世界の代謝バイオマーカー検査市場、検出技術のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素免疫測定（ELISA）
• ウェスタンブロッティング
• 蛍光ベースの検出
• 電気化学検出
• 核磁気共鳴（NMR）
• 免疫測定
• 世界の代謝バイオマーカー検査市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子バイオマーカー検査
• タンパク質バイオマーカー検査
• メタボロミクスプロファイリング
• 分光法技術
• マイクロアレイ技術

第7章 地域別・国別分析

• 世界の代謝バイオマーカー検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の代謝バイオマーカー検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 代謝バイオマーカー検査市場：競合情勢
• 代謝バイオマーカー検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• LECO Corporation
• Shimadzu Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• SCIEX
• Promega Corporation
• Cayman Chemical Company
• Metabolon Inc.
• Biocrates Life Sciences AG
• Human Metabolome Technologies Inc.
• KineMed Inc.
• Evosep Biosystems A/S
• Creative Proteomics Inc.
• Lipotype GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 代謝バイオマーカー検査市場2029：新たな機会を提供する国
• 代謝バイオマーカー検査市場2029：新たな機会を提供するセグメント
• 代謝バイオマーカー検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Metabolic biomarker testing involves analyzing specific molecules in biological samples, such as blood or urine, to evaluate metabolic processes and identify imbalances or dysfunctions. This testing is crucial for diagnosing metabolic disorders, monitoring health conditions, and developing personalized treatment strategies.

The primary types of metabolic biomarker testing include separation techniques, detection techniques, and other methods. Separation techniques utilize physical or chemical processes to isolate specific metabolites from biological samples based on properties such as size, charge, or affinity. This process aids in purifying and accurately identifying metabolic biomarkers. Indications for testing cover areas such as cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and more. Applications include drug assessment, nutrigenomics, toxicology testing, personalized medicine, and functional genomics. End users of metabolic biomarker testing include pharmaceutical and biotech companies, diagnostic tool companies, healthcare IT providers, and clinical laboratories.

The metabolic biomarker testing market research report is one of a series of new reports from the business research company that provides metabolic biomarker testing market statistics, including metabolic biomarker testing industry global market size, regional shares, competitors with an metabolic biomarker testing market share, detailed metabolic biomarker testing market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic biomarker testing industry. This metabolic biomarker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolic biomarker testing market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of metabolic disorders, rising awareness about early disease detection, growing demand for personalized medicine, increasing prevalence of obesity and diabetes, and growing adoption of preventive healthcare measures.

The metabolic biomarker testing market size is expected to see strong growth in the next few years. It will grow to $4.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on precision medicine, growth in personalized nutrition and wellness programs, increased funding for metabolic research, growing patient awareness and education, and rising prevalence of metabolic syndrome and related conditions. Major trends in the forecast period include advancements in high-throughput screening technologies, integration of artificial intelligence, integration of machine learning for biomarker analysis, advances in mobile health (mHealth) technologies, and expansion of telemedicine solutions for remote biomarker testing.

The increasing incidence of diabetes is expected to drive the growth of the metabolic biomarker testing market. Diabetes is a chronic condition marked by elevated blood glucose levels due to the body's inability to produce or properly use insulin. The rise in diabetes cases is influenced by poor dietary habits, particularly high consumption of processed foods and sugary drinks, along with sedentary lifestyles with minimal physical activity. Additionally, aging populations and family history of diabetes contribute to increased risk, indicating a genetic predisposition. Metabolic biomarker testing aids in diagnosing, monitoring, and managing metabolic diseases such as diabetes by providing detailed insights into metabolic functions and abnormalities at a molecular level. For example, in May 2024, the British Diabetic Association, a U.K.-based non-profit organization, reported that 4.3 million individuals in the UK are currently diagnosed with diabetes, with an increase of 148,951 cases in 2022 compared to 2021. Furthermore, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Thus, the rising incidence of diabetes is set to propel the growth of the metabolic biomarker testing market.

Major companies in the metabolic biomarker testing market are focusing on technological advancements, such as biowearables for self-monitoring, to enable users to continuously track and manage their nutritional and health indicators. These biowearables provide real-time, non-invasive monitoring of key metabolic markers such as glucose, supporting personalized health management and optimizing diet and athletic performance. For example, in January 2022, Abbott Laboratories, a US-based medical device company, introduced the Lingo biowearable. Designed to be worn on the upper arm for up to two weeks, it allows users to monitor glucose, ketone, and lactate levels, offering continuous insights into metabolic health. Utilizing technology from Abbott's FreeStyle Libre, the device aims to enhance general wellness and athletic performance rather than serving as a medical diagnostic tool. The initial launch was planned for Europe under the Lingo Keto brand, making it available directly to consumers without a prescription.

In June 2024, Lifesum AB, a Sweden-based provider of a healthy eating and wellness platform, acquired Lykon GmbH for an undisclosed amount. This acquisition is intended to integrate Lykon's biomarker testing into Lifesum's platform, enhancing the ability to offer personalized health insights, expanding wellness services, and bolstering Lifesum's position in the advanced wellness market. Lykon GmbH, based in Germany, specializes in personalized metabolic and nutritional testing.

Major companies operating in the metabolic biomarker testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., bioMerieux S.A., LECO Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, SCIEX, Promega Corporation, Cayman Chemical Company, Metabolon Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., KineMed Inc., Evosep Biosystems A/S, Creative Proteomics Inc., Lipotype GmbH, Metabolomic Diagnostics Ltd, Stemina Biomarker Discovery Inc., Chenomx Inc., GlycoPath Pty Ltd

North America was the largest region in the metabolic biomarker testing market in 2024. The regions covered in the metabolic biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metabolic biomarker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metabolic biomarker testing market consists of revenues earned by entities by providing services such as laboratory testing, analysis of blood, urine, and other biological samples, and personalized health assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic biomarker testing market also includes sales of diagnostic kits, assay reagents, and testing equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metabolic Biomarker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metabolic biomarker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metabolic biomarker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metabolic biomarker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Separation Techniques; Detection Techniques; Other Types
• 2) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors Of Metabolism; Other Indications
• 3) By Application: Drug Assessment; Nutrigenomics; Toxicology Testing; Personalized Medicine; Functional Genomics; Other Applications
• 4) By End User: Pharma And Biotech Companies; Diagnostic Tool Companies; Healthcare Information Technology (IT); Clinical Laboratories
• Subsegments:
• 1) By Separation Techniques: Chromatography; Capillary Electrophoresis; Mass Spectrometry (MS); Liquid-Liquid Extraction; Solid-Phase Extraction
• 2) By Detection Techniques: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting; Fluorescence-Based Detection; Electrochemical Detection; Nuclear Magnetic Resonance (NMR); Immunoassays
• 3) By Other Types: Genetic Biomarker Testing; Protein Biomarker Testing; Metabolomics Profiling; Spectroscopy Techniques; Microarray Technology
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; bioMerieux S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metabolic Biomarker Testing Market Characteristics

3. Metabolic Biomarker Testing Market Trends And Strategies

4. Metabolic Biomarker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Metabolic Biomarker Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Metabolic Biomarker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Metabolic Biomarker Testing Market Growth Rate Analysis
• 5.4. Global Metabolic Biomarker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Metabolic Biomarker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Metabolic Biomarker Testing Total Addressable Market (TAM)

6. Metabolic Biomarker Testing Market Segmentation

• 6.1. Global Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Separation Techniques
• Detection Techniques
• Other Types
• 6.2. Global Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Cardiovascular Diorders
• Neurological Disorders
• Inborn Errors Of Metabolism
• Other Indications
• 6.3. Global Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Assessment
• Nutrigenomics
• Toxicology Testing
• Personalized Medicine
• Functional Genomics
• Other Applications
• 6.4. Global Metabolic Biomarker Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharma And Biotech Companies
• Diagnostic Tool Companies
• Healthcare Information Technology (IT)
• Clinical Laboratories
• 6.5. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Separation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chromatography
• Capillary Electrophoresis
• Mass Spectrometry (MS)
• Liquid-Liquid Extraction
• Solid-Phase Extraction
• 6.6. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Detection Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Western Blotting
• Fluorescence-Based Detection
• Electrochemical Detection
• Nuclear Magnetic Resonance (NMR)
• Immunoassays
• 6.7. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Biomarker Testing
• Protein Biomarker Testing
• Metabolomics Profiling
• Spectroscopy Techniques
• Microarray Technology

7. Metabolic Biomarker Testing Market Regional And Country Analysis

• 7.1. Global Metabolic Biomarker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Metabolic Biomarker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metabolic Biomarker Testing Market

• 8.1. Asia-Pacific Metabolic Biomarker Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metabolic Biomarker Testing Market

• 9.1. China Metabolic Biomarker Testing Market Overview
• 9.2. China Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metabolic Biomarker Testing Market

• 10.1. India Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metabolic Biomarker Testing Market

• 11.1. Japan Metabolic Biomarker Testing Market Overview
• 11.2. Japan Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metabolic Biomarker Testing Market

• 12.1. Australia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metabolic Biomarker Testing Market

• 13.1. Indonesia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metabolic Biomarker Testing Market

• 14.1. South Korea Metabolic Biomarker Testing Market Overview
• 14.2. South Korea Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metabolic Biomarker Testing Market

• 15.1. Western Europe Metabolic Biomarker Testing Market Overview
• 15.2. Western Europe Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metabolic Biomarker Testing Market

• 16.1. UK Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metabolic Biomarker Testing Market

• 17.1. Germany Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metabolic Biomarker Testing Market

• 18.1. France Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metabolic Biomarker Testing Market

• 19.1. Italy Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metabolic Biomarker Testing Market

• 20.1. Spain Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metabolic Biomarker Testing Market

• 21.1. Eastern Europe Metabolic Biomarker Testing Market Overview
• 21.2. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metabolic Biomarker Testing Market

• 22.1. Russia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metabolic Biomarker Testing Market

• 23.1. North America Metabolic Biomarker Testing Market Overview
• 23.2. North America Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metabolic Biomarker Testing Market

• 24.1. USA Metabolic Biomarker Testing Market Overview
• 24.2. USA Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metabolic Biomarker Testing Market

• 25.1. Canada Metabolic Biomarker Testing Market Overview
• 25.2. Canada Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metabolic Biomarker Testing Market

• 26.1. South America Metabolic Biomarker Testing Market Overview
• 26.2. South America Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metabolic Biomarker Testing Market

• 27.1. Brazil Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metabolic Biomarker Testing Market

• 28.1. Middle East Metabolic Biomarker Testing Market Overview
• 28.2. Middle East Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metabolic Biomarker Testing Market

• 29.1. Africa Metabolic Biomarker Testing Market Overview
• 29.2. Africa Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metabolic Biomarker Testing Market Competitive Landscape And Company Profiles

• 30.1. Metabolic Biomarker Testing Market Competitive Landscape
• 30.2. Metabolic Biomarker Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Metabolic Biomarker Testing Market Other Major And Innovative Companies

• 31.1. LECO Corporation
• 31.2. Shimadzu Corporation
• 31.3. Waters Corporation
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. Bruker Corporation
• 31.6. SCIEX
• 31.7. Promega Corporation
• 31.8. Cayman Chemical Company
• 31.9. Metabolon Inc.
• 31.10. Biocrates Life Sciences AG
• 31.11. Human Metabolome Technologies Inc.
• 31.12. KineMed Inc.
• 31.13. Evosep Biosystems A/S
• 31.14. Creative Proteomics Inc.
• 31.15. Lipotype GmbH

32. Global Metabolic Biomarker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metabolic Biomarker Testing Market

34. Recent Developments In The Metabolic Biomarker Testing Market

35. Metabolic Biomarker Testing Market High Potential Countries, Segments and Strategies

• 35.1 Metabolic Biomarker Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Metabolic Biomarker Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Metabolic Biomarker Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33503_Metabolic_Biomarker_Testing_GMR_2025